CHRM1 and colonic neoplasm: Whereas, in azoxymethane-treated mice, ablating CHRM3 expression attenuates colon neoplasia [72,73], ablating CHRM1 did not significantly alter colon tumor number or size and, surprisingly, may have trended towards promoting colon neoplasia [76].